PSMA PET/CT and staging high risk prostate cancer: a non-systematic review of high clinical impact literature.
CONCLUSIONS: PSMA PET/CT has the potential to become a gold standard in staging high risk prostate cancer, providing clinicians with accurate information on the extent of disease within the prostate and the presence of loco-regional and distant metastatic disease within a single scan.
PMID: 32550630 [PubMed - as supplied by publisher]
Source: Minerva Urologica e Nefrologica - Category: Urology & Nephrology Tags: Minerva Urol Nefrol Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | PET Scan | Prostate Cancer | Study | Urology & Nephrology